DIAGNOS Inc. (ADK.V)
| Previous Close | 0.5300 |
| Open | 0.5100 |
| Bid | 0.5100 x 0 |
| Ask | 0.5300 x 0 |
| Day's Range | 0.5100 - 0.5300 |
| 52 Week Range | 0.1500 - 0.5900 |
| Volume | |
| Avg. Volume | 132,733 |
| Market Cap | 37.954M |
| Beta (5Y Monthly) | -0.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Nov 27, 2023 - Dec 01, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.00 |
- Baystreet
Diagnos, Appulse, Bedford at 52-Week Highs
Diagnos Inc. (V.ADK) hit a new 52-week high of 59 cents Friday. No news stories available today. Appulse ...
GlobeNewswireDIAGNOS Announces Closing of Private Placement and Exercise of Stock Warrants
BROSSARD, Quebec, May 18, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian corporation active in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing, today, of a non-brokered private placement (“Private Placement”) of unsecured convertible debentures (each a “Debenture”) and stock warrants (each a “Warrant”) for gross proceeds of $865,000.
GlobeNewswireDIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”
IRIS-ai powered by DIAGNOS IRIS-ai powered by DIAGNOS BROSSARD, Quebec, May 17, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the launch of “IRIS-ai powered by DIAGNOS” by IRIS, The Visual Group, in partnership with DIAGNOS. For over two years, IRIS and DIAGNOS have joined forces
